Familial Cancer

An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features

Paul Rozen, Ziona Samuel, Eli Brazowski, Markus Jakubowicz, Jacob Rattan, Zamir Halpern

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

Astrid T. Stormorken, Wolfram Müller, Annika Lindblom, Ketil Heimdal, Steinar Aase, Inger Marie Bowitz Lothe, Tove Norèn, Juul T. Wijnen, Gabriela Möslein, Pål Møller

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

Sara Levene, Gillian Scott, Patricia Price, Jeremy Sanderson, Helen Evans, Claire Taylor, Sylvia Bass, Cathryn Lewis, Shirley Hodgson

Quality of life in patients with multiple endocrine neoplasia type 1 (MEN1)

G. Berglund, A. Lidén, M. G. Hansson, K. Öberg, P. O. Sjöden, K. Nordin

The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing

Alexandre Sibert, David E. Goldgar

Attenuated familial adenomatous polyposis (AFAP): a review of the literature

Anne Lyster Knudsen, Marie Luise Bisgaard, Steffen Bülow

Genetic susceptibility to prostate cancer: a review

Bas A. J. Verhage, Lambertus A. L. M. Kiemeney

Instructions for authors